会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明申请
    • FOAMABLE COMPOSITIONS AND KITS COMPRISING ONE OR MORE OF A CHANNEL AGENT, A CHOLINERGIC AGENT, A NITRIC OXIDE DONOR, AND RELATED AGENTS AND THEIR USES
    • 包含一个或多个通道代理,化学试剂,氮氧化物和相关试剂及其用途的可燃组合物和试剂盒
    • WO2008110872A3
    • 2009-06-25
    • PCT/IB2007004522
    • 2007-06-22
    • FOAMIX LTDTAMARKIN DOVEINI MEIRFRIEDMAN DORONBERMAN TALBESONOV ALEX
    • TAMARKIN DOVEINI MEIRFRIEDMAN DORONBERMAN TALBESONOV ALEX
    • A61K9/00A61K9/12A61K31/44A61K31/506A61K31/55
    • A61K9/0014A61K9/122A61K9/1274A61K31/44A61K31/506A61K31/55A61K47/12A61K47/26A61K47/34A61K47/38
    • The present invention relates to a foamable therapeutic composition comprising: (a) a therapeutically effective concentration of at least one active agent selected from the group consisting of a channel agent, a cholinergic agent, and a nitric oxide donor; and (b) a foamable carrier comprising: i. about 50% to about 98% of a solvent selected from the group consisting of water; a hydrophilic solvent; a hydrophobic solvent; a potent solvent; a polar solvent, a silicone, an emollient, and mixtures thereof; ii. 0% to about 48% of a secondary solvent selected from the group consisting of water; a hydrophilic solvent; a hydrophobic solvent; a potent solvent; a polar solvent, a silicone, an emollient, a co-solvent, a penetration enhancer and mixtures thereof; iii. a surface-active agent; iv. about 0% to about 5% by weight of at least one polymeric agent; and v. a liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition; wherein the composition is housed in a container and is substantially flowable, and which upon release expands to form a breakable foam; and wherein the foamable carrier is selected to generate a foam of good to excellent quality. The invention further provides a method of treating, alleviating or preventing a disorder of mammalian subject, comprising administering such a composition to an afflicted target site.
    • 本发明涉及可发泡治疗组合物,其包含:(a)治疗有效浓度的至少一种选自通道剂,胆碱能药和一氧化氮供体的活性剂; 和(b)可发泡载体,包括:i。 约50%至约98%的选自水的溶剂; 亲水性溶剂; 疏水溶剂; 有效溶剂; 极性溶剂,硅氧烷,软化剂及其混合物; II。 0%至约48%的选自水的第二溶剂; 亲水性溶剂; 疏水溶剂; 有效溶剂; 极性溶剂,硅氧烷,软化剂,​​助溶剂,渗透增强剂及其混合物; III。 表面活性剂; IV。 约0重量%至约5重量%的至少一种聚合物; 和v。浓度为总组合物重量的约3%至约25%的液化或压缩气体推进剂; 其中所述组合物容纳在容器中并且基本上是可流动的,并且其在释放时膨胀以形成可破坏的泡沫; 并且其中所述可发泡载体被选择以产生良好至优异质量的泡沫。 本发明进一步提供治疗,减轻或预防哺乳动物受试者病症的方法,包括将所述组合物施用于受影响的靶位点。